We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Plaintiffs seeking to assert securities fraud claims against health-care companies based on the failure to disclose adverse event reports will not be required to allege that the reports were "statistically significant," the standard that had been articulated by a number of courts
In our rather terse (due to firm involvement) post on Monday concerning Merck & Co. v. Ratliff, ___ S.W.3d ___, 2012 WL 413522 (Ky. App. Feb. 10, 2012) beating both BNA and 360 by two days, BTW we mentioned the “interesting” aspects of that case
